Detailed answers about IW ADVANCED CLINICAL SOLUTIONS LIMITED, including incorporation, status, business activity, and accounts information.
When was IW ADVANCED CLINICAL SOLUTIONS LIMITED founded?
IW ADVANCED CLINICAL SOLUTIONS LIMITED was officially incorporated on 6 August 2026 and is registered under company number 17384740. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is IW ADVANCED CLINICAL SOLUTIONS LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of IW ADVANCED CLINICAL SOLUTIONS LIMITED?
IW ADVANCED CLINICAL SOLUTIONS LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does IW ADVANCED CLINICAL SOLUTIONS LIMITED do?
IW ADVANCED CLINICAL SOLUTIONS LIMITED operates in the following sectors: 86220 - Specialists medical practice activities, 86900 - Other human health activities. These SIC codes provide insight into the company's business activities and industry focus.
What is IW ADVANCED CLINICAL SOLUTIONS LIMITED's registered address?
The registered office address of IW ADVANCED CLINICAL SOLUTIONS LIMITED is C/O Stem Accountants Limited, Office 1, The Hive, St. James Square, Grimsby, North East Lincolnshire, United Kingdom, DN31 1EP. This is the official address filed with Companies House for legal and statutory correspondence.
Is IW ADVANCED CLINICAL SOLUTIONS LIMITED financially stable?
Financial accounts for IW ADVANCED CLINICAL SOLUTIONS LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.